Regulation of the melanoma cell adhesion molecule gene in melanoma: Modulation of mRNA synthesis by cyclic adenosine monophosphate, phorbol ester, and stem cell factor/c-Kit signaling

Journal of Investigative Dermatology

Volumn 113, Issue 5, 1999, Pages 711-719

  Karlen, Stéphane ^a,b   Braathen, Lasse R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

c Kit; Melanoma; Melanoma cell adhesion molecule; Sp1; Stem cell factor

Indexed keywords

CELL ADHESION MOLECULE; CYCLIC AMP; MELANOMA ANTIGEN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; STEM CELL FACTOR; TRANSCRIPTION FACTOR SP1;

ARTICLE; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; MELANOMA; MESSENGER RNA SYNTHESIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0032734796     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00746.x     Document Type: Article

References (40)

1. Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS, Ben-David Y: Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Cancer Res 56:3075-3086, 1996
2. Bar-Eli M: Molecular mechanisms of melanoma metastasis. J Cell Physiol 173:275-278, 1997
3. Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP, Ballotti R: Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 142:827-835, 1998
4. Blume-Jensen P, Siegbahn A, Stabel S, Heldin CH, Ronnstrand L: Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C. EMBO J 12:4199-4209, 1993
5. Blume-Jensen P, Wernstedt C, Heldin CH, Ronnstrand L: Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cells. J Biol Chem 270:14192-14200, 1995
6. Busca R, Bertolotto C, Abbe P, et al: Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell 9:1367-1378, 1998
7. Chen D, Rothenberg EV. Interleukin-2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 179:931-942, 1994
8. Derig HG, Burgess GS, Klinberg D, Dahreine TS, Mochizuku DY, Williams DE, Boswell HS: Role for cyclic AMP in the postreceptor control of cytokine stimulated stroma cell growth factor production. Leukemia 4:471-479, 1990
9. Dynan WS, Tjian R: The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35:79-87, 1983
10. Eisen TG: The control of gene expression in melanocytes and melanomas. Melanoma Res 6:277-284, 1996
11. Eisen T, Easty DJ, Bennett DC, Goding CR: The POU domain transcription factor Brn: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Oncogene 11:2157-2164, 1995
12. Fogh J, Fogh JM, Orfeo T: One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221-226, 1977
13. Funasaka Y, Boulton T, Cobb M, et al: C-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 3:197-209, 1992
14. Grimm T, Johnson JP: Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules. Cancer Res 55:3254-3257, 1995
15. Huang S, Luca M, Gutman M, McConkey DJ, Langley KE, Lyman SD, Bar-Eli M: Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential. Oncogene 13:2339-2347, 1996
16. Huang S, Jean D, Luca M, Tainsky MA, Bar-Eli M: Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J 17:4358-4369, 1998
17. Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M: Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem 273:16501-16508, 1998a
18. Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M: CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 273:24884-24890, 1998b
19. Karlen S, D'Ercole M, Sanderson CJ: Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0. Blood 88:211-221, 1996
20. Kraus A, Masat L, Johnson JP: Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen. Melanoma Res 7(Suppl. 2):S75-S81, 1997
21. Lassam N, Bickford S: Loss of c-kit expression in cultured melanoma cells. Oncogene 7:51-56, 1992
22. Lehmann JM, Holzmann B, Breithart EW, Schmiegelow P, Riethmuller G, Johnson JP: Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47:841-845, 1987
23. Longley BJJ, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 328:1302-1307, 1993
24. Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M: Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 3:35-41, 1993
25. Mancianti ML, Herlyn M: Tumor progression in melanoma: the biology of epidermal melanocytes in vitro. Carcinog Compr Surv 11:369-386, 1989
26. Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C, Herlyn M: Molecular events in melanoma development and progression. Front Biosci 3:D1005-D1010, 1998
27. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A: Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res 52:6139-6143, 1992
28. Rummel MM, Sers C, Johnson JP: Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM. Cancer Res 56:2218-2223, 1996
29. Schreiber E, Tobler A, Malipiero U, Schaffner W, Fontana A: CDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res 21:253-258, 1993
30. Sers C, Kirsch K, Rothbacher U, Riethmuller G, Johnson JP: Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains. Proc Natl Acad Sci USA 90:8514-8518, 1993
31. Shih IM, Elder DE, Hsu MY, Herlyn M: Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 145:837-845, 1994a
32. Shih IM, Elder DE, Speicher D, Johnson JP, Herlyn M: Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 54:2514-2520, 1994b
33. Singh RK, Gutman M, Reich R, Bar-Eli M: Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res 55:3669-3674, 1995
34. Smale ST, Baltimore D: The "initiator" as a transcription control element. Cell 57:103-113, 1989
35. Song S-K, Choi SY, Kim KT: Opposing effects of protein kinase A and C on capacitative calcium entry into HL-60 promyelocytes. Biochem Pharmacol 56:790-784, 1998
36. Verschraegen CF, Giovanella BC, Mendoza JT, Kozielski AJ, Stehlin JSJ: Specific organ metastases of human melanoma cells injected into the arterial circulation of nude mice. Anticancer Res 11:529-535, 1991
37. Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M: Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 57:2295-2303, 1997a
38. Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M: Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene 15:2069-2075, 1997b
39. Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR: Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 111:1053-1057, 1998
40. Zakut R, Perlis R, Eliyahu S, Yarden Y, Givol D, Lyman SD, Halaban R: KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. Oncogene 8:2221-2229, 1993